baclofen · Azurity · NDA 215602
Fleqsuvy
Earliest generic entry, as listed
29 Sep 2037
Blocked by patent: US 11324696.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11324696 | product | 29 Sep 2037 |
| US 11446246 | use U-3433 | 8 Sep 2037 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 215602 · 001 · RLD | suspension, oral | 25MG/5ML | 29 Sep 2037 |